
    
      A total 160 subjects (80 subjects every year, including 40 healthy controls and 40
      schizophrenia patients) will be recruited during a 2-year period. The first year, the
      baseline data of BDNF and Trk B DNA methylation, protein and mRNA levels in all subjects will
      be collected and the following 1 months data will also be collected in schizophrenia with
      antipsychotic drug treatments. The second year, the baseline data of BDNF and Trk B histone
      modification in all subjects will be collected.
    
  